FirstMark Company News

CRT 2013 Interview: Stephen E. Epstein, MD

An interview with Dr Stephen Epstein during the 2013 CRT conference. Both Dr Epstein and Dr Wilensky ( the interviewer) are members of FirstMark’s Scientific Advisory Board. To view the video for this interview, please click the following link: CRT … Continue reading →

FirstMark Scientific Board of Advisors Meet to Discuss New Clinical Studies for PREvent

SAN DIEGO, California – July 19, 2012 – FirstMark, provider of the groundbreaking cardiovascular blood test PREvent, announced the meeting of the Scientific Advisory Board, held today on July 19, 2012. The July meeting focused on the selection and planning … Continue reading →

FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium

SAN DIEGO, California – June 20, 2012 – FirstMark, the diagnostic division of GenWay Biotech, Inc., is pleased to announce that the company will be exhibiting and presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium, … Continue reading →

FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board

FirstMark advisory team helps guide the quality and relevance of FirstMark PREvent scientific information, future clinical studies, and approaches to clinical application SAN DIEGO, California – June 13, 2012 – FirstMark, the diagnostic division of GenWay Biotech, announced today that … Continue reading →

FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update

ATLANTA, Georgia – April 10, 2012 – FirstMark, the diagnostic division of GenWay Biotech, Inc., is pleased to announce that the company will be exhibiting at the inaugural Atlanta Clinical Cardiology Update (CCU), presented by the Division of Cardiology, Emory … Continue reading →

FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager

SAN DIEGO, Calif. & DALLAS – April 4, 2012 – FirstMark today announced the appointment of Jay Houtman as the company’s new Regional Sales Manager for the Southeast region of the United States. Houtman will be based out of Dallas … Continue reading →

FirstMark Exhibiting at the American College of Cardiology 61st Annual Scientific Sessions & Expo

CHICAGO, Illinois – March 23, 2011 – FirstMark, the diagnostic division of GenWay Biotech, Inc., is pleased to announce that the company will be exhibiting at the 61st Annual Scientific Sessions & Expo of the American College of Cardiology (ACC) … Continue reading →

Expanded Findings for FirstMark’s Completed Clinical Study for Predicting Near-Term (2-3 Years) MI

WASHINGTON D.C. – March 21, 2012, San Diego, California – FirstMark today announced further results from the completed clinical study for the multiple biomarker cardiovascular blood test PREvent. This follows the February 16, 2012 press release announcing the completion of … Continue reading →

Dr. Stephen Epstein to Present at Cardiology Grand Rounds at Washington Hospital Center

Presentation: An Aggregate of 3 Biomarkers Predict Very High Risk of Acute Myocardial Infarction and Death WASHINGTON D.C.– March 20, 2012 – Dr. Stephen E. Epstein, Director of Vascular Biology Research at the Cardiovascular Research Foundation at the Washington Hospital … Continue reading →

FirstMark PREvent Featured in the San Diego Business Journal

SAN DIEGO, California – February 20, 2012 – FirstMark PREvent, is featured in the San Diego Business Journal’s annual Biotechnology issue, February 20, 2012. The issue highlights exciting innovations in San Diego’s prevalent biotechnology industry. Read the featured article on … Continue reading →